The Value of Gene Therapy in the Stock Market

Cochlear has got a multi-decade runway, right? And the big watch out, the biggest bogeyman on the horizon is Gene Therapy. CSL is so dramatically enormously huge, both in absolute terms, $150 billion market cap. But more importantly, it dominates its field so almost completely that you have to have a pretty good sense of where the growth is going to come from. I've said millions of times with cochlear amazon one of the highest quality businesses in the country. What did I forget? It was so incredibly dominant so there wasn't enough growth left. You know what I would just suggest as an investor: Just be careful and don't get